By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Novogen Limited 

140 Wicks Road

North Ryde    NSW 2113  Australia
Phone: 203-327-1188 Fax: 203-327-0011



Company News
Novogen Limited (NVGN) Release: Graham Kelly Phd, CEO & Chairman Attended The Rodman & Renshaw 16th Annual Global Investment Conference 9/29/2014 12:59:42 PM
Novogen Limited (NVGN) Release: ABC TV Interview Discusses The Potential Of Trilexium(TM) To Treat Brain Cancer 9/29/2014 10:36:10 AM
Novogen Limited (NVGN) Announces Presentation At Rodman & Renshaw 16th Annual Healthcare Conference 9/5/2014 12:54:45 PM
Novogen Limited (NVGN) Announces Results Of General Meeting Of Shareholders 8/13/2014 8:32:23 AM
Novogen Limited (NVGN) Receives Funding Support To Commence Studies In Muscular Dystrophy 8/12/2014 9:21:04 AM
Novogen Limited (NVGN) And CanTx Appoint Contract Manufacturers To Produce Clinical Batches Of Cantrixil™ 7/25/2014 10:54:40 AM
Novogen Limited (NVGN) Touts Successful Proof-Of-Concept Studies For Trx-1 6/17/2014 6:48:49 AM
Novogen Limited (NVGN) Identifies Highly Active Drug Candidates Against Prostate Cancer 5/27/2014 9:27:24 AM
Novogen Limited (NVGN) And Genea Announce Partnership To Investigate Promising New Approach To Neurodegenerative Diseases 5/2/2014 8:57:02 AM
Novogen Limited (NVGN) To Present At 2nd Annual Sachs Cancer Bio Partnering & Investment Forum In New York 3/12/2014 9:34:50 AM